2 registrations that name policosanol as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 2 registrations
Status
Phase
All 2 registrations
RecruitingNCT05365425
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Phase 4
Seoul National University Bundang Hospital
About 56 people
Started Jun 1, 2023
In plain words A Phase 4 study of policosanol in people 20 and older, run by Seoul National University Bundang Hospital. It plans to enroll about 56 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 20 and older. Conditions: Dyslipidemia; Atherosclerosis; Diabetes Mellitus, Type 2.
Type 2 diabetes under treatment with HbA1c 6.0-10.0% at screening visit
Male or female of 20 years or over
Mixed dyslipidemia: triglyceride 200~499 mg/dL, HDL-cholesterol male ≤45 mg/dL or female ≤50 mg/dL
1 more inclusion criterion and the exclusion criteria are on the listing.
What it tests, as registered
Choline fenofibrate; Policosanol
Registered summary
This is a randomized controlled study to assess the effect of choline fenofibrate compared with policosanol in Korean T2DM patients with asymptomatic atherosclerosis.
Where, as registered
No US site; South Korea (1).
Not yet recruitingNCT07710261
Effects of Policosanol and Exercise on Fitness and Lipids in People With Elevated Blood Lipids
No phase
Mahidol University
About 120 people
Starts Jun 22, 2026 (estimated)
In plain words A study of policosanol in people 25 to 59, run by Mahidol University. It plans to enroll about 120 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 25 to 59. Conditions: Dyslipidemia; Elevated Blood Lipids; Physical Fitness; Exercise Training; Muscle Function, Handgrip Strength Test.
Men and women aged 25 to 59 years.
BMI between 18.5 and 29.9 kg/m².
Diagnosed with or presenting with dyslipidemia within the past 3 months, based on laboratory assessment at baseline or a standard laboratory report issued within the past 3 months, according to the National Cholesterol Education Program…
Total cholesterol ≥ 200 mg/dL;
8 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Policosanol; Placebo; Concurrent Exercise Training
Registered summary
This study will evaluate the effects of policosanol supplementation, concurrent exercise training, and their combination on physical fitness, muscle recovery, inflammatory markers, and blood lipid profiles in adults with elevated blood lipids who are not currently indicated for lipid-lowering medication. Participants will be randomly assigned to one of four groups for 12 weeks: policosanol plus exercise training, policosanol alone, placebo plus exercise training, or placebo without structured exercise training. The full summary is on the listing.